L090-3566 Screening compound: 1-(4-fluorophenyl)-6-methyl-7-oxo-N-[3-(trifluoromethyl)phenyl]-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide

L090-3566 Screening compound: 1-(4-fluorophenyl)-6-methyl-7-oxo-N-[3-(trifluoromethyl)phenyl]-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide
L090-3566 Screening compound: 1-(4-fluorophenyl)-6-methyl-7-oxo-N-[3-(trifluoromethyl)phenyl]-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L090-3566
1-(4-fluorophenyl)-6-methyl-7-oxo-N-[3-(trifluoromethyl)phenyl]-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L090-3566

Molecular Formula

C20H13F4N5O2 (C20 H13 F4 N5 O2)

Compound Name

1-(4-fluorophenyl)-6-methyl-7-oxo-N-[3-(trifluoromethyl)phenyl]-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide

IUPAC name

1-(4-fluorophenyl)-6-methyl-7-oxo-N-[3-(trifluoromethyl)phenyl]-1H6H7H-pyrazolo[43-d]pyrimidine-3-carboxamide

SMILES

CN(C=Nc1c2n(-c(cc3)ccc3F)nc1C(Nc1cc(C(F)(F)F)ccc1)=O)C2=O

InChI

InChI=1S/C20H13F4N5O2/c1-28-10-25-15-16(18(30)26-13-4-2-3-11(9-13)20(22,23)24)27-29(17(15)19(28)31)14-7-5-12(21)6-8-14/h2-10H,1H3,(H,26,30)

InChI Key

YCSFWMFFJVINLO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27231964

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.35

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.027

Distribution Coefficient, logD

2.769

Water Solubility, LogSw

-3.51

Polar Surface Area

61.417

Acid Dissociation Constant (pKa)

7.49

Base Dissociation Constant (pKb)

-2.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.00

L090-3566 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Anti-infective Library (19449 compounds)

Antiviral HBV Library (10007 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with L090-3566 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L090-3566?
Check Price and Availability of L090-3566, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L090-3566 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L090-3566
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L090-3566
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L090-3566 available by request